Clínica Baviera, S.A. (BME:CBAV)

Market Cap	893.83M +48.6%
Revenue (ttm)	304.91M +14.7%
Net Income	42.06M +4.6%
EPS	2.63 +4.5%
Shares Out	16.02M
PE Ratio	21.24
Forward PE	n/a
Dividend	1.57 (2.81%)
Ex-Dividend Date	Jun 10, 2026

Volume	1,847
Average Volume	2,589
Open	56.40
Previous Close	55.80
Day's Range	55.20 - 56.40
52-Week Range	37.70 - 58.00
Beta	0.77
RSI	65.74
Earnings Date	May 26, 2026

About Clínica Baviera

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmology, tear ducts, oculoplasty, lasik, and intraocular lenses treatments. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and chang...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1992
• Employees: 1,910
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: CBAV

Financial Performance

In 2025, Clínica Baviera's revenue was 304.91 million, an increase of 14.75% compared to the previous year's 265.72 million. Earnings were 42.06 million, an increase of 4.62%.